Wilson Sonsini Goodrich & Rosati advised Foresight on the deal. Foresight Diagnostics, Inc, a leading developer of ultrasensitive cancer detection tests, announced the close of an...
Foresight Diagnostics’ $58.75 Million Series B Financing Round
SetPoint Medical’s $80 Million Preferred Stock Financing
Wilson Sonsini Goodrich & Rosati advised SetPoint Medical on the deal. SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, announced an...
LinkedIn’s Acquisition of EduBrite
Wilson Sonsini Goodrich & Rosati advised LinkedIn on the deal. LinkedIn announced that it entered into an agreement to acquire EduBrite, a platform that specializes in...